← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Eleven Therapeutics Corp
Encintias, CA
$3,332,228
Total funding
2
Grants
Funding over time
peak $1.6M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,332,228 · 2
By mechanism
R42$3,012,228 · 1
R41$320,000 · 1
Investigators at Eleven Therapeutics Corp
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorder$1,567,215
R42 · FY2024 · DA
Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorder$1,445,013
R42 · FY2025 · DA
Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorder$320,000
R41 · FY2022 · DA